Family hope to raise £160k for groundbreaking stem cell treatment for daughter, Ivy, who suffers from cerebral palsy – Scottish Daily Record
Scottish Daily Record |
Family hope to raise £160k for groundbreaking stem cell treatment for daughter, Ivy, who suffers from cerebral palsy
Scottish Daily Record A connection through family led to meeting Dr Joanne Kurtzberg, who is awaiting approval from the US Food and Drug Administration for stem cell treatment with donor cells on cerebral palsy patients. Kurtzberg has agreed to accept Ivy on to the trial if … |
Trinidad & Tobago Express |
FDA announces first US gene therapy approval for cancer treatment
myfox8.com Each dose of Kymriah contains a patient’s own immune cells, which are sent to a lab to be genetically modified using a virus. This therapy — known as chimeric antigen receptor T–cell therapy, or CAR-T — gives the cells the ability to recognize and … CAR–T cancer treatment*Trinidad & Tobago Express FDA approves first ‘living drug’ for tough childhood leukemiaKTRK-TV US clears breakthrough gene therapy for childhood leukemiaWJHL Telegraph.co.uk –The Pharma Letter (registration) all 53 news articles » |
OzarksFirst.com |
FDA Approves New Cancer Treatment
OzarksFirst.com WASHINGTON – The Food and Drug Administration approved a treatment that engineers a patient’s own blood cells to fight the illness. It’s the first type of gene therapy to hit the US market. It has already been used to treat children dying from leukemia … |
Telegraph.co.uk |
US biotech Kite set to be first to launch one-time cancer gene therapy in Britain
Telegraph.co.uk US biotech Kite is expected to be first out of the blocks in Britain to launch a one-time genetic treatment for a type of cancer, in a global market expected to hit $54bn (£41.6bn) in value. The first so-called CAR-T treatment, developed by Swiss giant … |
The CT Mirror |
Kymriah, the First Gene Therapy, Arrives—With a $475000 Price Tag
ConsumerReports.org The Food and Drug Administration’s approval of Kymriah was met with excitement for its potential—as well as concerns about the $475,000 cost of this breakthrough gene therapy treatment for a life-threatening form of childhood cancer. In July, an FDA … Pioneering gene therapy gets green light — and $475000 priceThe CT Mirror Has the Era of Gene Therapy Finally Arrived?Scientific American (blog) First gene therapy that targets leukemia approved in the USKTIC BioWorld Online –CNBC –KTRK-TV all 38 news articles » |
South Bend Tribune |
South Bend man a ‘walking miracle’ after cancer treatment breakthrough
South Bend Tribune If that FDA approval comes — and UCM is preparing for it to come very soon — UCM will have one of the only facilities in the Midwest certified to administer chimeric antigen receptor T-cell infusion, or CAR T-cell, a newer form of immunotherapy. |